Category: Pharmaceuticals
United States Pharmaceuticals
-
Krill Oil
... CAGR of 10.1% over the analysis period 2024-2030. Softgels, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$485.1 Million by the end of the analysis period. ... Read More
-
Intrauterine Devices
... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Internet Ad Spending
... at a CAGR of 7.8% over the analysis period 2024-2030. Search, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$214.9 Billion by the end of the ... Read More
-
Hepatitis B Vaccines
... at a CAGR of 4.3% over the analysis period 2024-2030. Adult, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.7 Billion by the end of the ... Read More
-
Flavored Syrups
... CAGR of 4.4% over the analysis period 2024-2030. Beverages, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$25.5 Billion by the end of the analysis period. ... Read More
-
Counter Cyber Terrorism
... at a CAGR of 2.8% over the analysis period 2024-2030. Firewall, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$19.1 Billion by the end of the ... Read More
-
Prostate Cancer Diagnostics
... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of the ... Read More
-
Vancomycin
... 4.9% over the analysis period 2024-2030. Lung Infection, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. Growth ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion by ... Read More
-
Spring and Wire Products
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$47.0 Billion by the end ... Read More
-
Swine Health
... CAGR of 5.8% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. ... Read More
-
Sleeping Aids
... CAGR of 5.3% over the analysis period 2024-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$36.9 Billion by the end of the ... Read More
-
Online Home Rental Services
... 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Flats, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$40.3 Billion by the end ... Read More
-
Long-Term Care
... CAGR of 5.5% over the analysis period 2024-2030. Public Payer, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Trillion by the end of the analysis ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Garden Tools
... CAGR of 4.9% over the analysis period 2024-2030. Pruning Tools, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$50.8 Billion by the end of the analysis ... Read More
-
Artificial Insemination
... CAGR of 7.2% over the analysis period 2024-2030. Intrauterine, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis period. ... Read More
-
Veterinary Pain Management
... at a CAGR of 7.9% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end of the ... Read More
-
Intracranial Aneurysm
... CAGR of 8.7% over the analysis period 2024-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Hospitals and Outpatient Care Centers
... Trillion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.1 Trillion While China is Forecast to Grow at 7.6% CAGR The Hospitals and Outpatient ... Read More
-
Aesthetic Services
... CAGR of 7.0% over the analysis period 2024-2030. Surgical, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$17.1 Billion by the end of the analysis period. ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the end of ... Read More
-
Polyphenols
... 7.2% over the analysis period 2024-2030. Functional Beverages, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$855.9 Million by the end of the analysis period. Growth ... Read More
-
Pet Care
... CAGR of 6.1% over the analysis period 2024-2030. Pet Food, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$136.3 Billion by the end of the analysis ... Read More
Research Assistance
